Author:
Song Zhendong,Huang Shanshan,Yu Haiqing,Jiang Yu,Wang Changyuan,Meng Qiang,Shu Xiaohong,Sun Hunjun,Liu Kexin,Li Yanxia,Ma Xiaodong
Funder
National Natural Science Foundation of China
Cultivation Project of Youth Techstars, Dalian, China
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference35 articles.
1. Gefitinib (Iressa): a novel treatment for non-small cell lung cancer;Vansteenkiste;Expert Rev. Anticancer Ther.,2004
2. Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer;Tiseo;Curr. Med. Chem. Anti-Cancer Agents,2004
3. Erlotinib: a new therapeutic approach for non-small cell lung cancer;Bonomi;Expert Opin. Investig. Drugs,2003
4. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib;Kobayashi;N. Engl. J. Med.,2005
5. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain;Pao;PLoS Med.,2005
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献